Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$47.98 - $54.4 $14,393 - $16,320
300 Added 300.0%
400 $21,000
Q4 2023

Jan 26, 2024

BUY
$48.48 - $57.85 $4,848 - $5,785
100 New
100 $5,000
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $5,363 - $6,252
100 New
100 $6,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.